Learning Objectives:

  1. Understand the three most commonly used appetite stimulants and their indications
  2. Discover what current research is saying about the efficacy of appetite stimulants in the inpatient setting
  3. Describe two lipid administration methods currently believed to help prevent intestinal failure associated liver disease in neonatal and pediatric populations
  4. Recognize negative outcomes in either of these methods for the neonatal population
Session date: 
09/08/2023 - 12:00pm to 1:00pm CDT
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Macy Mears and Jennifer Sher